Scientists, operators, and advisors building the platform.
4th State Medical is led by a scientific founder with decades of regenerative research, an executive team with commercial and operating depth, and advisors chosen for domain expertise across biology, engineering, and translational medicine.
Scientific leadership.
Professor Emeritus of Surgery and Biomedical Engineering at UC Irvine with 520+ peer-reviewed publications and 50+ invited book chapters spanning diabetes, islet transplantation, stem cell technologies, and biomaterials. Co-inventor of the Edmonton Protocol — the landmark treatment for Type-1 diabetes via islet transplantation. Founder & CSO of a pet stem cell therapy company; co-founder of a stem cell banking and disease-differentiation transplant company. Globally recognized leader in stem cell and exosome-derived therapeutic products.
- Professor Emeritus, UC Irvine
- 520+ peer-reviewed publications
- Co-inventor, Edmonton Protocol
- Multiple issued & provisional patents
Executive team.
Chief Executive Officer leading corporate strategy, commercial development, and capital formation across the 4th State Medical platform.
Management & technology.
Chief Technology Officer overseeing device engineering, connected-platform architecture, and consumable authentication across the product portfolio.
Specialist scientific advisors.
Co-Founder / CEO of Cellarion Labs — a stem cell banking and cell differentiation company for diseases including diabetes, Alzheimer's, and autism. Managing Partner of the Longevity Venture Fund. Advises on stem cell biology, differentiation, and translational program design.
We selectively recruit scientists, engineers, and operators aligned with disciplined regenerative science. Reach out through the contact page.
Contact us →Investigators, clinical centers, and industry partners are welcome to propose collaborations aligned with the BioSignal research agenda.
Submit a proposal →